Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein
US5342764A · kind A · utility
8Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1993 |
| Grant date | Aug 30, 1994 |
| Priority date | — |
| Expiry date | Sep 1, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/851
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cloning and expression of the gene encoding human phospholipase inhibitory protein (hPIP) permits production of an anti-inflammatory protein in practical quantities using recombinant techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.